Related Experiment Video
Updated: Aug 16, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Thrombosis in Chronic Kidney Disease in Children
Tudor Ilie Lazaruc1, Lavinia Bodescu Amancei Ionescu1, Vasile Valeriu Lupu1
1Department of Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
Insights
Pediatric venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is rising due to medical advancements. This review covers VTE causes, diagnosis, and treatment in children, particularly those with chronic kidney disease.
Area of Science:
- Pediatric Hematology
- Nephrology
- Cardiology
Background:
- Pediatric venous thromboembolism (VTE) is increasingly recognized.
- Factors contributing to this rise include improved survival in chronic conditions like chronic kidney disease (CKD), increased catheter use, and enhanced diagnostic sensitivity.
- VTE in children carries significant risks, including higher mortality and post-thrombotic syndrome.
Purpose of the Study:
- To provide a state-of-the-art overview of pediatric thrombosis.
- To review the physiologic and pathologic mechanisms underlying VTE in children.
- To update current diagnostic and treatment strategies for pediatric VTE, with an emphasis on CKD patients.
Main Methods:
- Literature review of pediatric thrombosis.
- Analysis of VTE prevalence and risk factors in specific pediatric populations.
- Discussion of diagnostic and therapeutic approaches.
Main Results:
- VTE is associated with a 2-6 times higher mortality risk in children.
- Approximately 5% of pediatric VTE cases are linked to chronic kidney disease (CKD).
- VTE incidence is 3% in children with nephrotic syndrome (NS), with heightened risk in the first 6 months post-onset.
Conclusions:
- VTE in children, especially those with CKD, requires careful management due to associated risks.
- Understanding the underlying mechanisms and updated diagnostic/treatment options is crucial for improving outcomes.
- Further research and personalized approaches are needed for effective VTE prevention and treatment in pediatric populations.
Abstract:
Venous thromboembolism (VTE) in children is a rare condition. An increased incidence has been observed in the last few years due to several factors, such as increased survival in chronic conditions, especially chronic kidney disease (CKD), use of catheters, and increased sensitivity of diagnostic tools. VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE in children is associated with a two to six times higher mortality risk and a 5-10% prevalence of post-thrombotic syndrome. Overall, 5% of VTE episodes in children are associated with chronic kidney disease. The etiology of VTE in chronic kidney disease covers a wide range of pathologies. Various types of thrombotic complications may occur during long-term use of a chronic dialysis catheter. VTE occurs in 3% of children with nephrotic syndrome (NS). The risks for VTE and arterial thromboembolism (ATE) were particularly high in the first 6 months after the onset of NS. Other causes of VTE are graft rejection due to thrombosis of vascular anastomoses after kidney transplantation (3%) and autoimmune diseases (lupus nephritis, antiphospholipid syndrome). In this state-of-the-art overview, we have reviewed the physiologic and pathologic mechanisms underlying pediatric thrombosis and updated current diagnostic and treatment options, emphasizing personal experience as well.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

